Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastiano Filetti

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Molecular and Cellular Endocrinology|May 13, 2014
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumoursMarialuisa Sponziello, Cosimo Durante, Amelie Boichard, et al.
Medicine|February 9, 2017
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case reportElisa Giannetta, Andrea M Isidori, Cosimo Durante, et al.
Endocrine|April 2, 2020
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodulesMarialuisa Sponziello, Chiara Brunelli, Antonella Verrienti, et al.
International Journal of Oncology|April 11, 2017
MicroRNA-based molecular classification of papillary thyroid carcinomaFrancesca Rosignolo, Lorenzo Memeo, Fabio Monzani, et al.
Endocrine|April 4, 2015
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cellsMarialuisa Sponziello, Antonella Verrienti, Francesca Rosignolo, et al.
Thyroid : Official Journal of the American Thyroid Association|April 8, 2014
Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodiesCosimo Durante, Sara Tognini, Teresa Montesano, et al.
Cancers|January 23, 2020
Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk StratificationGiovanni Tallini, Antonio De Leo, Andrea Repaci, et al.
Endocrine-Related Cancer|July 13, 2016
RET mutation and increased angiogenesis in medullary thyroid carcinomasAntonella Verrienti, Giovanni Tallini, Chiara Colato, et al.
Human Mutation|December 9, 2017
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancerMarialuisa Sponziello, Silvia Benvenuti, Alessandra Gentile, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomasCosimo Durante, Marco Attard, Massimo Torlontano, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Molecular and Cellular Endocrinology|May 13, 2014
Epigenetic-related gene expression profile in medullary thyroid cancer revealed the overexpression of the histone methyltransferases EZH2 and SMYD3 in aggressive tumoursMarialuisa Sponziello, Cosimo Durante, Amelie Boichard, et al.
Medicine|February 9, 2017
Anaplastic thyroid carcinoma and foscarnet use in a multitarget treatment documented by 18F-FDG PET/CT: A case reportElisa Giannetta, Andrea M Isidori, Cosimo Durante, et al.
Endocrine|April 2, 2020
Performance of a dual-component molecular assay in cytologically indeterminate thyroid nodulesMarialuisa Sponziello, Chiara Brunelli, Antonella Verrienti, et al.
International Journal of Oncology|April 11, 2017
MicroRNA-based molecular classification of papillary thyroid carcinomaFrancesca Rosignolo, Lorenzo Memeo, Fabio Monzani, et al.
Endocrine|April 4, 2015
PDE5 expression in human thyroid tumors and effects of PDE5 inhibitors on growth and migration of cancer cellsMarialuisa Sponziello, Antonella Verrienti, Francesca Rosignolo, et al.
Thyroid : Official Journal of the American Thyroid Association|April 8, 2014
Clinical aggressiveness and long-term outcome in patients with papillary thyroid cancer and circulating anti-thyroglobulin autoantibodiesCosimo Durante, Sara Tognini, Teresa Montesano, et al.
Cancers|January 23, 2020
Does the Site of Origin of the Microcarcinoma with Respect to the Thyroid Surface Matter? A Multicenter Pathologic and Clinical Study for Risk StratificationGiovanni Tallini, Antonio De Leo, Andrea Repaci, et al.
Endocrine-Related Cancer|July 13, 2016
RET mutation and increased angiogenesis in medullary thyroid carcinomasAntonella Verrienti, Giovanni Tallini, Chiara Colato, et al.
Human Mutation|December 9, 2017
Whole exome sequencing identifies a germline MET mutation in two siblings with hereditary wild-type RET medullary thyroid cancerMarialuisa Sponziello, Silvia Benvenuti, Alessandra Gentile, et al.
The Journal of Clinical Endocrinology and Metabolism|July 28, 2010
Identification and optimal postsurgical follow-up of patients with very low-risk papillary thyroid microcarcinomasCosimo Durante, Marco Attard, Massimo Torlontano, et al.
Pageof 16